| Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia HM Parry, G McIlroy, R Bruton, M Ali, C Stephens, S Damery, A Otter, ... | 125 | 2021 |
| Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS G McIlroy, I Foldi, J Aurikko, JS Wentzell, MA Lim, JC Fenton, NJ Gay, ... Nature neuroscience 16 (9), 1248-1256, 2013 | 112 | 2013 |
| Are online symptoms checkers useful for patients with inflammatory arthritis? L Powley, G McIlroy, G Simons, K Raza BMC musculoskeletal disorders 17, 1-6, 2016 | 93 | 2016 |
| Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients MR Wilson, TA Eyre, AA Kirkwood, N Wong Doo, C Soussain, S Choquet, ... Blood, The Journal of the American Society of Hematology 139 (16), 2499-2511, 2022 | 62 | 2022 |
| Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report G McIlroy, L Ford, JM Khan BMC Pharmacology and Toxicology 17, 1-4, 2016 | 46 | 2016 |
| Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia H Parry, G McIlroy, R Bruton, S Damery, G Tyson, N Logan, C Davis, ... Journal of hematology & oncology 15 (1), 1-12, 2022 | 36 | 2022 |
| COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia H Parry, R Bruton, T Roberts, G McIlroy, S Damery, P Sylla, AC Dowell, ... Cancer cell 40 (6), 584-586, 2022 | 23 | 2022 |
| Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT … M Copland, D Slade, G McIlroy, G Horne, JL Byrne, K Rothwell, K Brock, ... The Lancet Haematology 9 (2), e121-e132, 2022 | 23 | 2022 |
| Trophic neuron‐glia interactions and cell number adjustments in the fruit fly A Hidalgo, K Kato, B Sutcliffe, G Mcilroy, S Bishop, S Alahmed Glia 59 (9), 1296-1303, 2011 | 23 | 2011 |
| The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis SK Thomas, J Hodson, G McIlroy, A Dhami, JJ Coleman Drug safety 36, 557-564, 2013 | 21 | 2013 |
| Kek-6: a truncated-Trk-like receptor for Drosophila neurotrophin 2 regulates structural synaptic plasticity S Ulian-Benitez, S Bishop, I Foldi, J Wentzell, C Okenwa, MG Forero, ... PLoS genetics 13 (8), e1006968, 2017 | 15 | 2017 |
| Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing G McIlroy, SK Thomas, JJ Coleman Journal of Public Health 37 (2), 346-352, 2015 | 15 | 2015 |
| Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival G McIlroy, J Mytton, F Evison, P Yadav, MT Drayson, M Cook, G Pratt, ... British journal of haematology 179 (1), 61-65, 2017 | 14 | 2017 |
| Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease FAM Kinsella, CF Inman, A Gudger, YT Chan, DJ Murray, J Zuo, G McIlroy, ... Leukemia research 83, 106173, 2019 | 13 | 2019 |
| A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial CP Fox, AS Ali, G McIlroy, S Thust, N Martinez-Calle, AE Jackson, ... Blood Advances 5 (20), 4073-4082, 2021 | 12 | 2021 |
| Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people H Parry, R Bruton, R Ayodele, P Sylla, G McIlroy, N Logan, S Scott, ... Cell Reports Medicine 3 (9), 2022 | 9 | 2022 |
| Treatment failure in patients receiving direct oral anticoagulants: clinical management and outcomes from a single-center review of 59 consecutive patients G McIlroy, N Smith, A Lokare, K Beale, C Kartsios Blood 132, 5058, 2018 | 9 | 2018 |
| Ibrutinib at first relapse for mantle cell lymphoma: a United Kingdom real world analysis of outcomes in 169 patients R McCulloch, S Rule, TA Eyre, H Goradia, S Bolam, T Creasey, D Tucker, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 5 | 2019 |
| Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial S Chaganti, S Maycock, G McIlroy, WA Iqbal, J Mason, E Kanfer, ... Blood 138, 2492, 2021 | 4 | 2021 |
| The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline CP Fox, S Chaganti, G McIlroy, SF Barrington, C Burton, K Cwynarski, ... British Journal of Haematology 204 (4), 1178-1192, 2024 | 3 | 2024 |
